“Glucagon-like peptide-1 receptor agonists in the treatment of cardiovascular diseases in patients with diabetes mellitus”, UJC, vol. 32, no. 3, pp. 71–82, Jun. 2025, doi: 10.31928/2664-4479-2025.3.7182.